$1.26
+0.05 (+4.13%)
Open$1.22
Previous Close$1.21
Day High$1.28
Day Low$1.19
52W High$23.23
52W Low$15.35
Volume—
Avg Volume99.4K
Market Cap231.04M
P/E Ratio28.58
EPS$0.60
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,710.3% upside
Current
$1.26
$1.26
Target
$22.81
$22.81
$15.42
$22.81 avg
$25.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 35.92M | 36.22M | 29.20M |
| Net Income | -2,667,111 | -2,507,722 | -2,038,148 |
| Profit Margin | -7.4% | -6.9% | -7.0% |
| EBITDA | -3,319,751 | -3,086,652 | -2,725,751 |
| Free Cash Flow | -2,830,658 | -2,753,402 | -2,024,759 |
| Rev Growth | +9.6% | +20.2% | -6.2% |
| Debt/Equity | 0.67 | 0.74 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |